205 related articles for article (PubMed ID: 2319513)
21. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
[TBL] [Abstract][Full Text] [Related]
22. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
Thabaut A; Meyran M
Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
[TBL] [Abstract][Full Text] [Related]
23. Evolution of beta-lactamase inhibitors.
Rolinson GN
Surg Gynecol Obstet; 1991; 172 Suppl():11-6. PubMed ID: 2024221
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.
Cuchural GJ; Snydman DR; McDermott L; Iannini PB; Hill GB; Cleary TJ; O'Keefe JP; Pierson CL; Rihs JD; Finegold SM
Clin Ther; 1992; 14(1):122-36. PubMed ID: 1576621
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.
Barry AL; Ayers LW; Gavan TL; Gerlach EH; Jones RN
Eur J Clin Microbiol; 1984 Jun; 3(3):203-6. PubMed ID: 6147246
[TBL] [Abstract][Full Text] [Related]
26. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.
Wybo I; Piérard D; Verschraegen I; Reynders M; Vandoorslaer K; Claeys G; Delmée M; Glupczynski Y; Gordts B; Ieven M; Melin P; Struelens M; Verhaegen J; Lauwers S
J Antimicrob Chemother; 2007 Jan; 59(1):132-9. PubMed ID: 17095529
[TBL] [Abstract][Full Text] [Related]
27. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
[TBL] [Abstract][Full Text] [Related]
28. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
[TBL] [Abstract][Full Text] [Related]
29. Parenteral beta-lactamase inhibitor combinations for clinical use.
Manzella JP
Am Fam Physician; 1995 May; 51(7):1695-8. PubMed ID: 7754928
[TBL] [Abstract][Full Text] [Related]
30. [Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
Cisterna R; Fresnadillo MJ; García-Rodríguez JA; Gobernado M; Martín R; Perea E; Picazo J
Rev Esp Quimioter; 1998 Sep; 11(3):245-50. PubMed ID: 9795311
[TBL] [Abstract][Full Text] [Related]
31. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
Werner H; Heizmann W; Heilmann F
Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity and in vivo evaluation of ticarcillin plus clavulanic acid against aerobic and anaerobic bacteria.
Bansal MB; Chuah SK; Thadepalli H
Am J Med; 1985 Nov; 79(5B):33-8. PubMed ID: 4073093
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of clinical bacterial isolates to Timentin (ticarcillin/clavulanic acid).
Villiger JW
N Z Med J; 1986 Nov; 99(814):914. PubMed ID: 3492692
[No Abstract] [Full Text] [Related]
34. Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
Fuchs PC; Jones RN; Barry AL; Allen SD; Aldridge KE; Gerlach EH; Sommers HM
Diagn Microbiol Infect Dis; 1988 Jan; 9(1):47-50. PubMed ID: 3370931
[TBL] [Abstract][Full Text] [Related]
35. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
[TBL] [Abstract][Full Text] [Related]
36. Ticarcillin/clavulanate in the treatment of pelvic infections.
Lucas MJ; Cox SM; Roark ML; Cunningham FG
J Reprod Med; 1990 Mar; 35(3 Suppl):343-7. PubMed ID: 2181121
[TBL] [Abstract][Full Text] [Related]
37. Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
Hill GB; Ayers OM; Everett BQ
J Antimicrob Chemother; 1991 Dec; 28(6):855-67. PubMed ID: 1816182
[TBL] [Abstract][Full Text] [Related]
38. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
Betriu C; Sánchez A; Gómez M; Palau ML; Picazo JJ
J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111
[TBL] [Abstract][Full Text] [Related]
39. A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis.
Sirinek KR; Levine BA
Surg Gynecol Obstet; 1991; 172 Suppl():30-5. PubMed ID: 2024224
[TBL] [Abstract][Full Text] [Related]
40. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.
Aldridge KE; Gelfand M; Reller LB; Ayers LW; Pierson CL; Schoenknecht F; Tilton RC; Wilkins J; Henderberg A; Schiro DD
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):235-41. PubMed ID: 7924220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
